CCM
BIIB icon

Catapult Capital Management’s Biogen BIIB Stock Holding History

Catapult Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-10,000
Closed -$4.04M – 159
2015
Q2 		$4.04M Buy
+10,000
New +$4.01M 0.58% 48

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Catapult Capital Management's BIIB Position: Q3 2015 in Review

Catapult Capital Management sold out of Biogen (BIIB) in Q3 2015, closing a stake of 10,000 shares — an estimated $4.04M sold.

Catapult Capital Management first reported a position in BIIB in Q2 2015 and held it in 1 quarter. The position peaked at $4.04M in Q2 2015. 924 funds tracked by Wall St. Rank hold BIIB as of Q3 2015.

  • Catapult Capital Management reported no remaining Biogen position as of Q3 2015 after selling out during the quarter.
  • Catapult Capital Management sold 10,000 Biogen shares in Q3 2015, an estimated $4.04M.
  • Catapult Capital Management first reported a position in Biogen in Q2 2015 and held it in 1 quarter.
  • Catapult Capital Management's Biogen position peaked at $4.04M in Q2 2015.
  • 924 funds tracked by Wall St. Rank held Biogen as of Q3 2015.

Based on Catapult Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.